Licensing & acquisition

At Trinity, we help our clients develop and implement transaction-driven strategies.

Practice area overview

We provide meticulous, objective, and actionable assessments of US and global licensing and acquisition opportunities. We pride ourselves on rapid response and a record of delivering top-quality work in high-pressure situations for difficult projects.

Breadth of experience

We can support all aspects of the business development process—from opportunity identification to deal negotiation. Our expertise in science and business strategy forms the basis for balanced and comprehensive recommendations that consider both the technical and the commercial aspects of the deal.

Range of assessments

We’ve completed hundreds of assessments in a vast array of therapeutic areas and technology platforms, including short- (filed/launched), mid- (Phase IIb - III) and long-term (preclinical - Phase IIa) opportunities. 

The 3 "C's"

We challenge our clients to consider all aspects of potential deals—clinical value-add, commercial opportunity, and company fit. Using this framework, we can systematically and effectively evaluate diverse opportunities.